Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery. (Q36745501)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Cristian Rodriguez-Aguayo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Junhua Mai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Arturo Chavez-Reyes

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

19

Anil K Sood

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Haifa Shen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Rong Xu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Vianey Gonzalez-Villasana

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Yi Huang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Guodong Zhang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Xiaojing Guo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Litao Bai

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Guoting Qin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Xiaoyong Deng

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Qingpo Li

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Donald R Erm

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Burcu Aslan

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Xuewu Liu

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jason Sakamoto

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Hee-Dong Han

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Mauro Ferrari

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Gabriel Lopez-Berestein

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

5 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

1806-1815

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice

23 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Cooperative, nanoparticle-enabled thermal therapy of breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Nanovector delivery of siRNA for cancer therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Chemotherapy dosing schedule influences drug resistance development in ovarian cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Logic-embedded vectors for intracellular partitioning, endosomal escape, and exocytosis of nanoparticles

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Sustained small interfering RNA delivery by mesoporous silicon particles

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Frontiers in cancer nanomedicine: directing mass transport through biological barriers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Beyond chemotherapy: targeted therapies in ovarian cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

EphA2 overexpression is associated with angiogenesis in ovarian cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

EphA2 expression is associated with aggressive features in ovarian carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Vectoring siRNA therapeutics into the clinic

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Size and shape effects in the biodistribution of intravascularly injected particles.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

EphA2 overexpression causes tumorigenesis of mammary epithelial cells.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Overexpression of the EphA2 tyrosine kinase in prostate cancer.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618564

10.1158/1078-0432.CCR-12-2764

4 December 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

release_cjhllv5cu5bmjlxf6uthzcv2ze

23 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cjhllv5cu5bmjlxf6uthzcv2ze

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386691%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

23386691

1 reference